inVentiv Medical Management and Proventys Form Collaboration to Deliver a New Standard in Evidence-Based Oncology Care Management Programs

NEWTON, Mass. and AUGUSTA, Ga., Oct. 13, 2011 /PRNewswire/ -- inVentiv Medical Management (formerly AWAC®), a pioneer in accountable care solutions in multiple disease areas including oncology, and Proventys, a leader in clinical decision support technology, have launched a commercial relationship to serve the needs of payers, providers, and cancer patients nationwide.  

Together, the companies will provide a next-generation quality oncology program aimed at reducing variability of care, improving outcomes, and lowering overall cost of care. An integrated services offering enabled by both the Proventys CDS Oncology™ system and inVentiv Medical Management's clinically accountable care solution will be delivered by a multi-disciplinary team, led by an in-house oncologist and supported by certified oncology nurses, case management, social work and nutrition professionals.

Proventys CDS Oncology is a dynamic, web-based decision support tool that presents the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), customizable pathways and payer coverage policies at the point of care. The system offers clinicians and care managers guidance on appropriate lab and imaging tests, provides information on cancer staging and highlights the most relevant treatment regimens based on NCCN Guidelines® and patient-specific characteristics.

"By collaborating with inVentiv Medical Management, we have a major opportunity to bring a truly innovative service offering to the hands of highly-skilled clinicians who touch the lives and support the care of thousands of patients living with cancer, while also serving as an effective bridge with payers, employers and other entities," said Timothy Thompson, Chief Executive Officer at Proventys.  "Clinicians and payers alike rely heavily on the NCCN Guidelines® as the de facto standard to deliver evidence-based care for patients and health plan members, and we have developed a system and service offering that make these Guidelines personalized and actionable for clinicians and care managers, like those on inVentiv Medical Management's multidisciplinary team."

The Proventys and inVentiv Medical Management service offering is intended to support oncology care management programs sponsored by third-party administrators, employers, payers and other entities.  As a whole, health plans and employers have seen the complexity and cost of cancer escalate significantly over the past five years, due in part to the challenges clinicians face in keeping up with evidence and recommended practice guidelines.  With rapidly increasing costs and the need to support high-quality, personalized care for patients being treated for cancer, Proventys and inVentiv Medical Management are committed to delivering a higher standard of oncology care management.

"We are very excited about the new relationship with Proventys, which adds an additional dimension of differentiation to our cancer care management solution," said Marc Palmer, Chief Executive Officer at inVentiv Medical Management.  "The collaboration will support our team's mission to ensure the delivery of evidence-based, cost-effective cancer care, advance operational quality, and enable outcomes reporting with enhanced granularity. This innovation reinforces our company mission overall and galvanizes the value of our accountable care solutions."

About inVentiv Medical Management

inVentiv Medical Management (formerly AWAC), an inVentiv Health company, is a leading national provider of physician directed, nurse supported, technology enabled, medical management solutions to third party administrators ("TPAs"), self-funded or fully insured plans, employer groups, managing general underwriters (MGUs"), and insurance carriers. With a mission of improving healthcare costs, quality and outcomes, we deliver balanced clinical surveillance and cost intervention that supports payers, providers and patients. inVentiv Medical Management is headquartered in Augusta, Georgia. Please visit www.inVentivMM.com for more information.

About inVentiv Health

inVentiv Health, Inc. is a leading global provider of best-in-class clinical, commercial and consulting services to companies seeking to accelerate performance. inVentiv's client roster includes more than 550 pharmaceutical, biotech and life sciences companies. With 13,000 employees in 40 countries, inVentiv rapidly transforms promising ideas into commercial reality. inVentiv Health, Inc. is privately owned by inVentiv Group Holdings Inc., an organization sponsored by affiliates of Thomas H. Lee Partners, L.P., Liberty Lane Partners and members of the inVentiv management team. For more information, visit http://www.inventivhealth.com.

About Proventys

Proventys is a healthcare technology and services company that provides innovative decision support and medical management solutions to help clinicians optimize care for patients on a personalized basis.  The Company has an exclusive relationship with the National Comprehensive Cancer Network® (NCCN®) to develop and commercialize the Proventys CDS Oncology™ system, a novel decision support platform that dynamically renders the NCCN Guidelines®, customizable clinical pathways and payer-specific coverage policies, presenting clinicians with relevant treatment options based on individual patient characteristics.  Based in Newton, Massachusetts, Proventys is dedicated to aligning the interests of patients, providers and payers by offering solutions that personalize care and improve outcomes.  For more information, visit www.proventys.com.

SOURCE inVentiv Medical Management